Andrew Stephen Thomis Sells 19,224 Shares of Cohort plc (LON:CHRT) Stock

Cohort plc (LON:CHRTGet Free Report) insider Andrew Stephen Thomis sold 19,224 shares of the business’s stock in a transaction on Monday, July 22nd. The stock was sold at an average price of GBX 808 ($10.45), for a total value of £155,329.92 ($200,892.29).

Cohort Trading Up 3.4 %

Shares of CHRT stock opened at GBX 854 ($11.05) on Friday. Cohort plc has a 1 year low of GBX 456 ($5.90) and a 1 year high of GBX 874.38 ($11.31). The company has a debt-to-equity ratio of 32.14, a quick ratio of 0.93 and a current ratio of 1.69. The stock has a fifty day moving average of GBX 801.86 and a two-hundred day moving average of GBX 695.77. The firm has a market capitalization of £345.02 million, a PE ratio of 2,587.88 and a beta of 0.51.

Cohort Increases Dividend

The company also recently disclosed a dividend, which will be paid on Wednesday, October 2nd. Stockholders of record on Thursday, August 22nd will be paid a GBX 10.10 ($0.13) dividend. This represents a dividend yield of 1.22%. The ex-dividend date is Thursday, August 22nd. This is an increase from Cohort’s previous dividend of $4.70. Cohort’s payout ratio is currently 4,242.42%.

Analyst Ratings Changes

Separately, Shore Capital reiterated a “buy” rating on shares of Cohort in a research report on Monday, July 15th.

Get Our Latest Stock Report on Cohort

About Cohort

(Get Free Report)

Cohort plc, through its subsidiaries, provides various products and services in defense, security, and related markets in the United Kingdom, Germany, Portugal, Africa, North and South America, and the Asia Pacific and Africa. The company offers electro-optical and electro-mechanical systems, such as command, control, communications, computers, intelligence, surveillance, target acquisition, and reconnaissance, as well as combat systems; and communications systems.

Featured Stories

Receive News & Ratings for Cohort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cohort and related companies with MarketBeat.com's FREE daily email newsletter.